1 Study Coverage
    1.1 Infection Prevention and Enteral Access Product Introduction
    1.2 Market by Type
        1.2.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Enteral Feeding Pumps
        1.2.3 Enteral Feeding Tubes
        1.2.4 Administration Reservoirs
        1.2.5 Giving Sets
        1.2.6 Enteral Syringes
    1.3 Market by Application
        1.3.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Gastroenterology
        1.3.4 Diabetes
        1.3.5 Neurological Disorders
        1.3.6 Hypermetabolism
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Infection Prevention and Enteral Access Sales Estimates and Forecasts 2017-2028
    2.2 Global Infection Prevention and Enteral Access Revenue Estimates and Forecasts 2017-2028
    2.3 Global Infection Prevention and Enteral Access Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Infection Prevention and Enteral Access Sales by Region
        2.4.1 Global Infection Prevention and Enteral Access Sales by Region (2017-2022)
        2.4.2 Global Sales Infection Prevention and Enteral Access by Region (2023-2028)
    2.5 Global Infection Prevention and Enteral Access Revenue by Region
        2.5.1 Global Infection Prevention and Enteral Access Revenue by Region (2017-2022)
        2.5.2 Global Infection Prevention and Enteral Access Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Infection Prevention and Enteral Access Sales by Manufacturers
        3.1.1 Global Top Infection Prevention and Enteral Access Manufacturers by Sales (2017-2022)
        3.1.2 Global Infection Prevention and Enteral Access Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infection Prevention and Enteral Access in 2021
    3.2 Global Infection Prevention and Enteral Access Revenue by Manufacturers
        3.2.1 Global Infection Prevention and Enteral Access Revenue by Manufacturers (2017-2022)
        3.2.2 Global Infection Prevention and Enteral Access Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Infection Prevention and Enteral Access Revenue in 2021
    3.3 Global Infection Prevention and Enteral Access Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Infection Prevention and Enteral Access Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Infection Prevention and Enteral Access Sales by Type
        4.1.1 Global Infection Prevention and Enteral Access Historical Sales by Type (2017-2022)
        4.1.2 Global Infection Prevention and Enteral Access Forecasted Sales by Type (2023-2028)
        4.1.3 Global Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    4.2 Global Infection Prevention and Enteral Access Revenue by Type
        4.2.1 Global Infection Prevention and Enteral Access Historical Revenue by Type (2017-2022)
        4.2.2 Global Infection Prevention and Enteral Access Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    4.3 Global Infection Prevention and Enteral Access Price by Type
        4.3.1 Global Infection Prevention and Enteral Access Price by Type (2017-2022)
        4.3.2 Global Infection Prevention and Enteral Access Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Infection Prevention and Enteral Access Sales by Application
        5.1.1 Global Infection Prevention and Enteral Access Historical Sales by Application (2017-2022)
        5.1.2 Global Infection Prevention and Enteral Access Forecasted Sales by Application (2023-2028)
        5.1.3 Global Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    5.2 Global Infection Prevention and Enteral Access Revenue by Application
        5.2.1 Global Infection Prevention and Enteral Access Historical Revenue by Application (2017-2022)
        5.2.2 Global Infection Prevention and Enteral Access Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    5.3 Global Infection Prevention and Enteral Access Price by Application
        5.3.1 Global Infection Prevention and Enteral Access Price by Application (2017-2022)
        5.3.2 Global Infection Prevention and Enteral Access Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Infection Prevention and Enteral Access Market Size by Type
        6.1.1 North America Infection Prevention and Enteral Access Sales by Type (2017-2028)
        6.1.2 North America Infection Prevention and Enteral Access Revenue by Type (2017-2028)
    6.2 North America Infection Prevention and Enteral Access Market Size by Application
        6.2.1 North America Infection Prevention and Enteral Access Sales by Application (2017-2028)
        6.2.2 North America Infection Prevention and Enteral Access Revenue by Application (2017-2028)
    6.3 North America Infection Prevention and Enteral Access Market Size by Country
        6.3.1 North America Infection Prevention and Enteral Access Sales by Country (2017-2028)
        6.3.2 North America Infection Prevention and Enteral Access Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Infection Prevention and Enteral Access Market Size by Type
        7.1.1 Europe Infection Prevention and Enteral Access Sales by Type (2017-2028)
        7.1.2 Europe Infection Prevention and Enteral Access Revenue by Type (2017-2028)
    7.2 Europe Infection Prevention and Enteral Access Market Size by Application
        7.2.1 Europe Infection Prevention and Enteral Access Sales by Application (2017-2028)
        7.2.2 Europe Infection Prevention and Enteral Access Revenue by Application (2017-2028)
    7.3 Europe Infection Prevention and Enteral Access Market Size by Country
        7.3.1 Europe Infection Prevention and Enteral Access Sales by Country (2017-2028)
        7.3.2 Europe Infection Prevention and Enteral Access Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Infection Prevention and Enteral Access Market Size by Type
        8.1.1 Asia Pacific Infection Prevention and Enteral Access Sales by Type (2017-2028)
        8.1.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Type (2017-2028)
    8.2 Asia Pacific Infection Prevention and Enteral Access Market Size by Application
        8.2.1 Asia Pacific Infection Prevention and Enteral Access Sales by Application (2017-2028)
        8.2.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Application (2017-2028)
    8.3 Asia Pacific Infection Prevention and Enteral Access Market Size by Region
        8.3.1 Asia Pacific Infection Prevention and Enteral Access Sales by Region (2017-2028)
        8.3.2 Asia Pacific Infection Prevention and Enteral Access Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Infection Prevention and Enteral Access Market Size by Type
        9.1.1 Latin America Infection Prevention and Enteral Access Sales by Type (2017-2028)
        9.1.2 Latin America Infection Prevention and Enteral Access Revenue by Type (2017-2028)
    9.2 Latin America Infection Prevention and Enteral Access Market Size by Application
        9.2.1 Latin America Infection Prevention and Enteral Access Sales by Application (2017-2028)
        9.2.2 Latin America Infection Prevention and Enteral Access Revenue by Application (2017-2028)
    9.3 Latin America Infection Prevention and Enteral Access Market Size by Country
        9.3.1 Latin America Infection Prevention and Enteral Access Sales by Country (2017-2028)
        9.3.2 Latin America Infection Prevention and Enteral Access Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Infection Prevention and Enteral Access Market Size by Type
        10.1.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Type (2017-2028)
    10.2 Middle East and Africa Infection Prevention and Enteral Access Market Size by Application
        10.2.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Application (2017-2028)
    10.3 Middle East and Africa Infection Prevention and Enteral Access Market Size by Country
        10.3.1 Middle East and Africa Infection Prevention and Enteral Access Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Infection Prevention and Enteral Access Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Cook Medical
        11.1.1 Cook Medical Corporation Information
        11.1.2 Cook Medical Overview
        11.1.3 Cook Medical Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Cook Medical Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Cook Medical Recent Developments
    11.2 Medtronic Plc
        11.2.1 Medtronic Plc Corporation Information
        11.2.2 Medtronic Plc Overview
        11.2.3 Medtronic Plc Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Medtronic Plc Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Medtronic Plc Recent Developments
    11.3 Boston Scientific Corporation
        11.3.1 Boston Scientific Corporation Corporation Information
        11.3.2 Boston Scientific Corporation Overview
        11.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Boston Scientific Corporation Recent Developments
    11.4 CONMED Corporation
        11.4.1 CONMED Corporation Corporation Information
        11.4.2 CONMED Corporation Overview
        11.4.3 CONMED Corporation Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 CONMED Corporation Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 CONMED Corporation Recent Developments
    11.5 CORPAK MedSystems
        11.5.1 CORPAK MedSystems Corporation Information
        11.5.2 CORPAK MedSystems Overview
        11.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 CORPAK MedSystems Recent Developments
    11.6 CR Bard
        11.6.1 CR Bard Corporation Information
        11.6.2 CR Bard Overview
        11.6.3 CR Bard Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 CR Bard Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 CR Bard Recent Developments
    11.7 ALCOR Scientific
        11.7.1 ALCOR Scientific Corporation Information
        11.7.2 ALCOR Scientific Overview
        11.7.3 ALCOR Scientific Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 ALCOR Scientific Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 ALCOR Scientific Recent Developments
    11.8 Pacific Hospital Supply
        11.8.1 Pacific Hospital Supply Corporation Information
        11.8.2 Pacific Hospital Supply Overview
        11.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Pacific Hospital Supply Recent Developments
    11.9 Teleflexorporated
        11.9.1 Teleflexorporated Corporation Information
        11.9.2 Teleflexorporated Overview
        11.9.3 Teleflexorporated Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Teleflexorporated Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Teleflexorporated Recent Developments
    11.10 Vygon SA
        11.10.1 Vygon SA Corporation Information
        11.10.2 Vygon SA Overview
        11.10.3 Vygon SA Infection Prevention and Enteral Access Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Vygon SA Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Vygon SA Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Infection Prevention and Enteral Access Industry Chain Analysis
    12.2 Infection Prevention and Enteral Access Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Infection Prevention and Enteral Access Production Mode & Process
    12.4 Infection Prevention and Enteral Access Sales and Marketing
        12.4.1 Infection Prevention and Enteral Access Sales Channels
        12.4.2 Infection Prevention and Enteral Access Distributors
    12.5 Infection Prevention and Enteral Access Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Infection Prevention and Enteral Access Industry Trends
    13.2 Infection Prevention and Enteral Access Market Drivers
    13.3 Infection Prevention and Enteral Access Market Challenges
    13.4 Infection Prevention and Enteral Access Market Restraints
14 Key Findings in The Global Infection Prevention and Enteral Access Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Infection Prevention and Enteral Access Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Enteral Feeding Pumps
    Table 3. Major Manufacturers of Enteral Feeding Tubes
    Table 4. Major Manufacturers of Administration Reservoirs
    Table 5. Major Manufacturers of Giving Sets
    Table 6. Major Manufacturers of Enteral Syringes
    Table 7. Global Infection Prevention and Enteral Access Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Infection Prevention and Enteral Access Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Infection Prevention and Enteral Access Sales by Region (2017-2022) & (K Units)
    Table 10. Global Infection Prevention and Enteral Access Sales Market Share by Region (2017-2022)
    Table 11. Global Infection Prevention and Enteral Access Sales by Region (2023-2028) & (K Units)
    Table 12. Global Infection Prevention and Enteral Access Sales Market Share by Region (2023-2028)
    Table 13. Global Infection Prevention and Enteral Access Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Infection Prevention and Enteral Access Revenue Market Share by Region (2017-2022)
    Table 15. Global Infection Prevention and Enteral Access Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Infection Prevention and Enteral Access Revenue Market Share by Region (2023-2028)
    Table 17. Global Infection Prevention and Enteral Access Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Infection Prevention and Enteral Access Sales Share by Manufacturers (2017-2022)
    Table 19. Global Infection Prevention and Enteral Access Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Infection Prevention and Enteral Access Revenue Share by Manufacturers (2017-2022)
    Table 21. Infection Prevention and Enteral Access Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Infection Prevention and Enteral Access Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Infection Prevention and Enteral Access by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Prevention and Enteral Access as of 2021)
    Table 24. Infection Prevention and Enteral Access Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Infection Prevention and Enteral Access Product Offered
    Table 26. Date of Manufacturers Enter into Infection Prevention and Enteral Access Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Infection Prevention and Enteral Access Sales by Type (2017-2022) & (K Units)
    Table 29. Global Infection Prevention and Enteral Access Sales by Type (2023-2028) & (K Units)
    Table 30. Global Infection Prevention and Enteral Access Sales Share by Type (2017-2022)
    Table 31. Global Infection Prevention and Enteral Access Sales Share by Type (2023-2028)
    Table 32. Global Infection Prevention and Enteral Access Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Infection Prevention and Enteral Access Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Infection Prevention and Enteral Access Revenue Share by Type (2017-2022)
    Table 35. Global Infection Prevention and Enteral Access Revenue Share by Type (2023-2028)
    Table 36. Infection Prevention and Enteral Access Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Infection Prevention and Enteral Access Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Infection Prevention and Enteral Access Sales by Application (2017-2022) & (K Units)
    Table 39. Global Infection Prevention and Enteral Access Sales by Application (2023-2028) & (K Units)
    Table 40. Global Infection Prevention and Enteral Access Sales Share by Application (2017-2022)
    Table 41. Global Infection Prevention and Enteral Access Sales Share by Application (2023-2028)
    Table 42. Global Infection Prevention and Enteral Access Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Infection Prevention and Enteral Access Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Infection Prevention and Enteral Access Revenue Share by Application (2017-2022)
    Table 45. Global Infection Prevention and Enteral Access Revenue Share by Application (2023-2028)
    Table 46. Infection Prevention and Enteral Access Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Infection Prevention and Enteral Access Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Infection Prevention and Enteral Access Sales by Type (2017-2022) & (K Units)
    Table 49. North America Infection Prevention and Enteral Access Sales by Type (2023-2028) & (K Units)
    Table 50. North America Infection Prevention and Enteral Access Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Infection Prevention and Enteral Access Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Infection Prevention and Enteral Access Sales by Application (2017-2022) & (K Units)
    Table 53. North America Infection Prevention and Enteral Access Sales by Application (2023-2028) & (K Units)
    Table 54. North America Infection Prevention and Enteral Access Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Infection Prevention and Enteral Access Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Infection Prevention and Enteral Access Sales by Country (2017-2022) & (K Units)
    Table 57. North America Infection Prevention and Enteral Access Sales by Country (2023-2028) & (K Units)
    Table 58. North America Infection Prevention and Enteral Access Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Infection Prevention and Enteral Access Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Infection Prevention and Enteral Access Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Infection Prevention and Enteral Access Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Infection Prevention and Enteral Access Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Infection Prevention and Enteral Access Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Infection Prevention and Enteral Access Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Infection Prevention and Enteral Access Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Infection Prevention and Enteral Access Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Infection Prevention and Enteral Access Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Infection Prevention and Enteral Access Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Infection Prevention and Enteral Access Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Infection Prevention and Enteral Access Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Infection Prevention and Enteral Access Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Infection Prevention and Enteral Access Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Infection Prevention and Enteral Access Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Infection Prevention and Enteral Access Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Infection Prevention and Enteral Access Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Infection Prevention and Enteral Access Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Infection Prevention and Enteral Access Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Infection Prevention and Enteral Access Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Infection Prevention and Enteral Access Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Infection Prevention and Enteral Access Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Infection Prevention and Enteral Access Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Infection Prevention and Enteral Access Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Infection Prevention and Enteral Access Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Infection Prevention and Enteral Access Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Infection Prevention and Enteral Access Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Infection Prevention and Enteral Access Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Infection Prevention and Enteral Access Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Infection Prevention and Enteral Access Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Infection Prevention and Enteral Access Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Infection Prevention and Enteral Access Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Infection Prevention and Enteral Access Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Infection Prevention and Enteral Access Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Infection Prevention and Enteral Access Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Infection Prevention and Enteral Access Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Infection Prevention and Enteral Access Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Infection Prevention and Enteral Access Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Infection Prevention and Enteral Access Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Infection Prevention and Enteral Access Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Infection Prevention and Enteral Access Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Infection Prevention and Enteral Access Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Infection Prevention and Enteral Access Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Infection Prevention and Enteral Access Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Infection Prevention and Enteral Access Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Infection Prevention and Enteral Access Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Infection Prevention and Enteral Access Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Infection Prevention and Enteral Access Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Infection Prevention and Enteral Access Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Cook Medical Corporation Information
    Table 109. Cook Medical Description and Major Businesses
    Table 110. Cook Medical Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Cook Medical Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Cook Medical Recent Developments
    Table 113. Medtronic Plc Corporation Information
    Table 114. Medtronic Plc Description and Major Businesses
    Table 115. Medtronic Plc Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Medtronic Plc Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Medtronic Plc Recent Developments
    Table 118. Boston Scientific Corporation Corporation Information
    Table 119. Boston Scientific Corporation Description and Major Businesses
    Table 120. Boston Scientific Corporation Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Boston Scientific Corporation Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Boston Scientific Corporation Recent Developments
    Table 123. CONMED Corporation Corporation Information
    Table 124. CONMED Corporation Description and Major Businesses
    Table 125. CONMED Corporation Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. CONMED Corporation Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. CONMED Corporation Recent Developments
    Table 128. CORPAK MedSystems Corporation Information
    Table 129. CORPAK MedSystems Description and Major Businesses
    Table 130. CORPAK MedSystems Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. CORPAK MedSystems Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. CORPAK MedSystems Recent Developments
    Table 133. CR Bard Corporation Information
    Table 134. CR Bard Description and Major Businesses
    Table 135. CR Bard Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. CR Bard Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. CR Bard Recent Developments
    Table 138. ALCOR Scientific Corporation Information
    Table 139. ALCOR Scientific Description and Major Businesses
    Table 140. ALCOR Scientific Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. ALCOR Scientific Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. ALCOR Scientific Recent Developments
    Table 143. Pacific Hospital Supply Corporation Information
    Table 144. Pacific Hospital Supply Description and Major Businesses
    Table 145. Pacific Hospital Supply Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Pacific Hospital Supply Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Pacific Hospital Supply Recent Developments
    Table 148. Teleflexorporated Corporation Information
    Table 149. Teleflexorporated Description and Major Businesses
    Table 150. Teleflexorporated Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Teleflexorporated Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Teleflexorporated Recent Developments
    Table 153. Vygon SA Corporation Information
    Table 154. Vygon SA Description and Major Businesses
    Table 155. Vygon SA Infection Prevention and Enteral Access Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Vygon SA Infection Prevention and Enteral Access Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Vygon SA Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Infection Prevention and Enteral Access Distributors List
    Table 161. Infection Prevention and Enteral Access Customers List
    Table 162. Infection Prevention and Enteral Access Market Trends
    Table 163. Infection Prevention and Enteral Access Market Drivers
    Table 164. Infection Prevention and Enteral Access Market Challenges
    Table 165. Infection Prevention and Enteral Access Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Infection Prevention and Enteral Access Product Picture
    Figure 3. Global Infection Prevention and Enteral Access Market Share by Type in 2021 & 2028
    Figure 3. Enteral Feeding Pumps Product Picture
    Figure 4. Enteral Feeding Tubes Product Picture
    Figure 5. Administration Reservoirs Product Picture
    Figure 6. Giving Sets Product Picture
    Figure 7. Enteral Syringes Product Picture
    Figure 8. Global Infection Prevention and Enteral Access Market Share by Application in 2021 & 2028
    Figure 9. Oncology
    Figure 10. Gastroenterology
    Figure 11. Diabetes
    Figure 12. Neurological Disorders
    Figure 13. Hypermetabolism
    Figure 14. Others
    Figure 15. Infection Prevention and Enteral Access Report Years Considered
    Figure 16. Global Infection Prevention and Enteral Access Sales 2017-2028 (K Units)
    Figure 17. Global Infection Prevention and Enteral Access Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Infection Prevention and Enteral Access Revenue 2017-2028 (US$ Million)
    Figure 19. Global Infection Prevention and Enteral Access Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Infection Prevention and Enteral Access Sales Market Share by Region (2017-2022)
    Figure 21. Global Infection Prevention and Enteral Access Sales Market Share by Region (2023-2028)
    Figure 22. North America Infection Prevention and Enteral Access Sales YoY (2017-2028) & (K Units)
    Figure 23. North America Infection Prevention and Enteral Access Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Infection Prevention and Enteral Access Sales YoY (2017-2028) & (K Units)
    Figure 25. Europe Infection Prevention and Enteral Access Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Infection Prevention and Enteral Access Sales YoY (2017-2028) & (K Units)
    Figure 27. Asia-Pacific Infection Prevention and Enteral Access Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Infection Prevention and Enteral Access Sales YoY (2017-2028) & (K Units)
    Figure 29. Latin America Infection Prevention and Enteral Access Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Infection Prevention and Enteral Access Sales YoY (2017-2028) & (K Units)
    Figure 31. Middle East & Africa Infection Prevention and Enteral Access Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Infection Prevention and Enteral Access Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Infection Prevention and Enteral Access in the World: Market Share by Infection Prevention and Enteral Access Revenue in 2021
    Figure 34. Global Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    Figure 36. Global Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    Figure 37. Global Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    Figure 38. Global Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    Figure 39. North America Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    Figure 40. North America Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    Figure 41. North America Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    Figure 42. North America Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    Figure 43. North America Infection Prevention and Enteral Access Sales Share by Country (2017-2028)
    Figure 44. North America Infection Prevention and Enteral Access Revenue Share by Country (2017-2028)
    Figure 45. U.S. Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    Figure 48. Europe Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    Figure 50. Europe Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Infection Prevention and Enteral Access Sales Share by Country (2017-2028)
    Figure 52. Europe Infection Prevention and Enteral Access Revenue Share by Country (2017-2028)
    Figure 53. Germany Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 54. France Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Infection Prevention and Enteral Access Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Infection Prevention and Enteral Access Revenue Share by Region (2017-2028)
    Figure 64. China Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 67. India Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Infection Prevention and Enteral Access Sales Share by Country (2017-2028)
    Figure 79. Latin America Infection Prevention and Enteral Access Revenue Share by Country (2017-2028)
    Figure 80. Mexico Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Infection Prevention and Enteral Access Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Infection Prevention and Enteral Access Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Infection Prevention and Enteral Access Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Infection Prevention and Enteral Access Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Infection Prevention and Enteral Access Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Infection Prevention and Enteral Access Revenue Share by Country (2017-2028)
    Figure 89. Turkey Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 91. U.A.E Infection Prevention and Enteral Access Revenue (2017-2028) & (US$ Million)
    Figure 92. Infection Prevention and Enteral Access Value Chain
    Figure 93. Infection Prevention and Enteral Access Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed